𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy

✍ Scribed by Uwe Wollina; Jürgen Füller; Tim Graefe; Martin Kaatz; Eric Lopatta

Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
130 KB
Volume
127
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel in the treatment of patients
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
✍ Farid Fata; Eileen O'Reilly; David Ilson; David Pfister; David Leffel; David P. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

## BACKGROUND. Angiosarcomas are rare tumors. Based on a complete response observed in a patient with angiosarcoma of the scalp treated with paclitaxel in a Phase II trial, the authors treated a cohort of patients with angiosarcoma of the scalp or face with paclitaxel as single agent. ## METHODS.

Outcomes after definitive treatment for
Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp
✍ B. Ashleigh Guadagnolo; Gunar K. Zagars; Dejka Araujo; Vinod Ravi; Thomas D. She 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract ## Background The aim of the present analysis was to retrospectively evaluate outcomes in patients with cutaneous angiosarcoma of the face/scalp treated curatively with surgery, radiation therapy (RT), or a combination of surgery and RT. ## Methods In all, 70 patients with nonmetasta

Successful treatment of severe refractor
Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin
✍ Cosgriff, Thomas M.; Black, Marcus L.; Stein, William 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 13 KB 👁 2 views

Idiopathic thrombocytopenic purpura (ITP) is refractory to initial treatment (steroids and splenectomy) in 25 to 30% of patients. These patients have a significant risk of fatal hemorrhage. Two patients with ITP refractory to multiple interventions and severe depression of platelet counts responded